Prevalence and drug resistance of Escherichia coli among patients with orthopaedic surgical site infections in China: A systematic review and meta-analysis

To summarize current prevalence and drug resistance rate of Escherichia coli (E. coli) among orthopaedic surgical site infections (SSIs) in China from English and Chinese language sources. Online databases were searched to collect related researches. A meta-analysis was performed to analyse prevalence and 95 % confidence interval (CI) of E. coli among patients with orthopedic surgical site infections. Meta-regression analysis was used to investigate the difference in the prevalence and antimicrobial resistance of E. coli among different subgroups. A total of 52 studies were enrolled into our meta-analysis, with a total of 31,285 strains isolated. The overall E. coli prevalence was 13.4 % (95 % CI 11.6–15.5). Study design (R(2) = 8.98) and sample size (R(2) = 10.95) might be potential sources of heterogeneity and there were no significant differences in risk of bias (R(2) = 0.28), study time (R(2) < 0.01), region (R(2) = 2.46) and hospital level (R(2) = 1.42). E. coli resistance were reported in 43 of the 52 papers. Antimicrobial resistance of E. coli to Ampicillin [87.9 % (95 % CI 83.7–91.1)] before 2015 was higher than that after 2015 [80.3 % (95 % CI 75.0–84.7)] (R(2) = 30.93, P = 0.033). While, resistance rate to Cefepime and Amikacin was significantly higher before 2015 (R(2) = 17.25 and 6.54, P = 0.043 and 0.048), i.e., 46.4 % (36.3–56.9), 19.9 % (13.8–27.7) and 29.1 % (19.4–41.2), 8.6 % (4.4–16.2) in 2015 and after. It is necessary to carry out long-term monitoring to understand the actual prevalence and antimicrobial resistance of E. coli to develop appropriate health care mechanisms.